Bain Capital Life Sciences Partners, LP, Director, 10% Owner at Dicerna Pharmaceuticals Inc (DRNA), bought 475,849 shares at $7.00 ($2.0M) on 2017-12-18, disclosed to the SEC on 2017-12-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 190,849 | $0 | 0.0% |
| 2 | $7.00 | 285,000 | $2.0M | 100.0% |
| Total | $4.19 avg | 475,849 | $2.0M | 100% |